Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03791645 · ClinicalTrials.gov registry record · NA

Evaluating The Efficacy Of A Mind-Body Intervention In Overcoming Opioid Addiction

A NA study of Opioid Use Disorder and Opioid Use, sponsored by Ohio State University.

Completed
Registry status
NA
Development phase
61
Enrollment target
1
Study location

NCT03791645 is a NA study of Opioid Use Disorder and Opioid Use that has completed, run by Ohio State University. The registered enrollment target is 61 participants, below the 4,656-participant average among 257 other Opioid Use Disorder trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03791645, a NA study of Opioid Use Disorder and Opioid Use, has completed, sponsored by Ohio State University.

COMPLETED
Registry status
NA
Development phase
61 participants
Enrollment target
1
Study location

Study Summary

This study demonstrates the feasibility, acceptability of SKY program as an adjuvant therapy for American population suffering with OUD through a pilot program in Columbus, Ohio. The aim of this study is to evaluate the SKY program as an adjuvant therapy to treat opioid addiction.

Interventions

  • BEHAVIORAL Sky Intervention

Study Locations (1)

Ohio

  • The Ohio State University College of Social Work - Columbus

Trial Details

FieldValue
Enrollment Target 61 participants
Start Date 2018-10-27
Est. Completion 2022-03-31
Phase NA

Sponsor

Ohio State University

552 total trials

What the Registry Record Tells You About NCT03791645

The ClinicalTrials.gov registry entry for NCT03791645 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 61 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 4,656-participant average among 257 other Opioid Use Disorder trials with a reported enrollment target (99% lower). The listed sponsor is Ohio State University, which has 552 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Opioid Use Disorder appearing as the primary indexed condition, and to 1 intervention - of which Sky Intervention is the first listed.

NCT03791645 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.

Frequently Asked Questions

What is clinical trial NCT03791645 about?

NCT03791645 is a clinical study titled "Evaluating The Efficacy Of A Mind-Body Intervention In Overcoming Opioid Addiction". This study demonstrates the feasibility, acceptability of SKY program as an adjuvant therapy for American population suffering with OUD through a pilot program in Columbus, Ohio. The aim of this study is to evaluate the SKY program as an adjuvant therapy to treat opioid addiction.

What is the current status of trial NCT03791645?

This trial is currently completed. It is a NA study. The enrollment target is 61 participants. The study started on 2018-10-27. Estimated completion is 2022-03-31.

What conditions does trial NCT03791645 study?

This clinical trial studies the following conditions: Opioid Use Disorder, Opioid Use, Substance Use Disorders.

What interventions are being tested in trial NCT03791645?

The interventions under investigation include: Sky Intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT03791645?

This trial is sponsored by Ohio State University, which has 552 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03791645 being conducted?

This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Opioid Use Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.